Reforço contra Omicron tem proteção modesta
Fonte: FirstWord Pharma Leia a notícia como publicada originalmente pelo portal FirstWord: Real-world study findings released by the US Centers for Disease Control and Prevention (CDC) found that bivalent COVID-19 booster shots targeting the Omicron strain provided “significant additional protection” against symptomatic infection, according to the agency. “These are the first published estimates of [vaccine
